Global Sarcopenia Therapeutic Pipeline Review, H2 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Sarcopenia - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

Sarcopenia - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Sarcopenia (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The Sarcopenia (Musculoskeletal Disorders) pipeline guide also reviews key players involved in therapeutic development for Sarcopenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 4, 1, 7 and 3 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 2 molecules, respectively.

Sarcopenia (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Report Coverage
  3. Sarcopenia - Overview
  4. Sarcopenia - Therapeutics Development
  5. Pipeline Overview
  6. Pipeline by Companies
  7. Pipeline by Universities/Institutes
  8. Products under Development by Companies
  9. Products under Development by Universities/Institutes
  10. Sarcopenia - Therapeutics Assessment
  11. Assessment by Target
  12. Assessment by Mechanism of Action
  13. Assessment by Route of Administration
  14. Assessment by Molecule Type
  15. Sarcopenia - Companies Involved in Therapeutics Development
  • Amgen Inc
  • Biophytis SA
  • Faraday Pharmaceuticals Inc
  • GlaxoSmithKline Plc
  • Immusoft Corp
  • MYOS RENS Technology Inc
  • Neurotune AG
  • Novartis AG
  • Regeneron Pharmaceuticals Inc
  • ST Pharm Co., Ltd.
  • Teijin Pharma Ltd

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/bblbrc/global_sarcopenia?w=4.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Musculoskeletal Disorders Drugs, Drugs by Therapeutic Area

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Musculoskeletal Disorders Drugs, Drugs by Therapeutic Area